POLYGON Therapeutics
PrivateLast Round
Seed
Nov 8, 2024
Total Funding Raised
$8M
Company Overview
POLYGON Therapeutics is a drug discovery company that provides a therapeutic development program to improve cardiovascular disease care and mitigate the damage inflicted on the heart.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
POLYGON Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
POLYGON Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 8, 2024 | ||||
| Grant | Apr 18, 2023 | ||||
| Pre Seed | Sep 8, 2022 | ||||
| Grant | Jul 7, 2022 |
Key People
Founding team and executive leadership
POLYGON Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agoranov | Pre Seed |
| Région Île-de-France | Grant |
| Audacia | Seed |
| Inserm Transfert | Pre Seed |
| EIT Health | Seed |
| Sorbonne Venture | Seed |
| Bpifrance | Grant, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Monthly visitors increased 42% MoM.
- Feb 23, 2025
Monthly visitors grew 408% MoM.
POLYGON Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about POLYGON Therapeutics's valuation, stock price, and market status.